Endothelins potentiate formalin-induced nociception and paw edema in mice

Canadian Journal of Physiology and Pharmacology

Volumn 75, Issue 6, 1997, Pages 596-600

  Piovezan, Anna Paula ^a   D'Orléans Juste, Pedro ^b   Tonussi, C R ^a   Rae, Giles A ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^b UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

Bosentan; Edema; Endothelin; Formalin; Histamine; Inflammation; Mouse; Nociception

Indexed keywords

BOSENTAN; ENDOTHELIN 1; ENDOTHELIN 3; ENDOTHELIN RECEPTOR ANTAGONIST; FORMALDEHYDE; HISTAMINE; SARAFOTOXIN S6C;

ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL;

EID: 0030696083     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/y97-057     Document Type: Conference Paper

References (27)

1. Arai, H., Hori, S., Aramori, I., Ohkubo, H., and Nakanishi, S. 1990. Cloning and expression of a cDNA encoding an endothelin receptor. Nature (London), 348: 730-732.
2. Battistini, B., Forget, M.-A., and Laight, D. 1996. Potential roles for endothelins in systemic inflammatory response syndrome with a particular relationship to cytokines. Shock, 5: 167-183.
3. Brain, S.D., Thomas, G., Crossman, D.C., Fuller, R., and Church, M.K. 1992. Endothelin-1 induces a histamine-dependent flare in vivo, but does not activate human skin mast cells in vitro. Br. J. Pharmacol. 33: 117-120.
4. Clozel, M., Breu, V., Gray, G.A., Kalina, B., Löffler, B.-M., Burri, K., Cassal, J.-M., Hirth, G., Müller, M., Neidhart, W., and Ramuz, H. 1994. Pharmacological characterization of bosentan, a new potent orally active non-peptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 270: 228-235.
5. Dahlof, B., Gustafsson, D., Hedner, D., Jern, S., and Hansson, L. 1990. Regional hemodynamic effects of endothelin-1 in rat and man: unexpected adverse reactions. J. Hypertens. 8: 811.
6. D'Orléans-Juste, P., Claing, A., Regoli, D., Sirois, P., and Plante, G.E. 1996. Endothelial and smooth muscle pharmacology of pre- and postcapillary microcirculation: correlation with plasma extravasation. Prostaglandins Leukotrienes Essent. Fatty Acids, 54: 31-37.
7. Douglas, S.A., Beck, G.R., Jr., Elliot, J.D., and Ohlstein, E.H. 1995. Pharmacological evidence for the presence of three distinct functional endothelin receptor subtypes in the rabbit lateral saphenous vein. Br. J. Pharmacol. 114: 1529-1540.
8. Ehrenreich, H., Burd, P.R., Rottem, M., Hültner, L., Hylton, J.B., Garfield, M., Colligan, J.E., Metcalfe, D.D., and Fauci, A.S. 1992. Endothelins belong to the assortment of mast cell-derived and mast-cell bound cytokines. New Biol. 4: 147-154.
9. Emori, T., Hirata, Y., and Marumo, F. 1990. Specific receptors for endothelin-3 in cultured bovine endothelial cells and its cellular mechanism of action. FEBS Lett. 263: 261-264.
10. Ferreira, S.H., Romitelli, M., and De Nucci, G. 1989. Endothelin-1 participation in overt and inflammatory pain. J. Cardiovasc. Pharmacol. 13(Suppl. 5): 220-222.
11. Filep, J.G., Télémaque, S., Battistini, B., Sirois, P., and D'Orleans-Juste, P. 1993. Increased plasma levels of endothelin during anaphylactic shock in the guinea-pig. Eur. J. Pharmacol. 239: 231-236.
12. 2. Br. J. Pharmacol. 112: 963-971.
13. B receptors. Br. J. Pharmacol. 115: 227-236.
14. Hunskaar, S., and Hole, K. 1987. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain, 30: 103-114.
15. Hyslop, S., and De Nucci, G. 1992. Vasoactive mediators released by endothelins. Pharmacol. Res. 26: 223-242.
16. C receptor) from Xenopus laevis dermal melanophores. J. Biol. Chem. 268: 19 126-19 133.
17. Klemm, P., Warner, T.D., Hohlfeld, T., Corder, R., and Vane, J.R. 1995. Endothelin-1 mediates ex vivo coronary vasoconstriction caused by exogenous and endogenous cytokines. Proc. Natl. Acad. Sci. U.S.A. 92: 2691-2695.
18. B receptors in rat skin and an investigation of their function in the cutaneous microvasculature. Br. J. Pharmacol. 115: 840-844.
19. Masaki, T., Vane, J.R., and Vanhoutte, P.M. 1994. International Union of Pharmacology nomenclature of endothelin receptors. Pharmacol. Rev. 46: 137-142.
20. Mattoli, S., Soloperto, M., Marinni, M., and Fasoli, A. 1991. Levels of endothelin-1 in the brochoalveolar lavage fluid of patients with symptomatic asthma and reversible airflow obstruction. J. Allergy Clin. Immunol. 88: 376-384.
21. Miyasaka, N., Hirata, Y., Ando, K., Sato, K., Morita, H., Shichiri, M., Kanno, K., Tomito, K., and Marumo, F. 1992. Increased production of endothelin-1 in patients with inflammatory arthritides. Arthritis Rheum. 35: 397-400.
22. Raffa, R.B., and Jacoby, H.I. 1991. Endothelin-1, -2 and -3 directly and big-endothelin-1 indirectly elicit an abdominal constriction response in mice. Life Sci. 48: 85-90.
23. B receptors. J. Pharmacol. Exp. Ther. 276: 647-651.
24. Sakurai, T., Yanagisawa, M., Takuwa, Y., Miyazaki, H., Kimura, S., Goto, K., and Masaki, T. 1990. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (London), 348: 732-735.
25. A receptor antagonists inhibit allergic inflammation in the mouse. J. Cardiovasc. Pharmacol. 26(Suppl. 3): 416-418.
26. Shibata, M., Ohkubo, T., Takahashi, H., and Inoki, R. 1989. Modified formalin test: characteristic biphasic pain response. Pain, 38: 347-352.
27. Yamamura, H., Nabe, T., Kohno, S., and Ohata, K. 1994. Endothelin-1, one of the most potent histamine releasers in mouse peritoneal mast cells. Eur. J. Pharmacol. 265: 9-15.